Tetsuro Kondo

Yokohama, 2418515, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting Anaplastic Lymphoma Kinase Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort Study.

Comparison of Amplicon-Based Next-Generation Sequencing Testing and Immunohistochemical Staining in Detecting Anaplastic Lymphoma Kinase Fusion Genes in Non-Small-Cell Lung Cancer: A Large Single-Centre Cohort Study.

Journal: Cancers

Published: June 03, 2026

Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP.

Gut microbiome functional pathways outperform taxonomic profiles in predicting immune checkpoint inhibitor response in non-small cell lung cancer: an interpretable machine learning approach with SHAP.

Journal: Frontiers in immunology

Published: March 17, 2026

Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report.

Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report.

Journal: Respiratory investigation

Published: February 01, 2026

Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Clinical Utility of Comprehensive Genomic Profiling for Advanced Non-Small Cell Lung Cancer: A Single-Center Retrospective Study.

Journal: Thoracic cancer

Published: September 22, 2025

Maternal copy number variations detected by noninvasive prenatal testing in Japanese women.

Maternal copy number variations detected by noninvasive prenatal testing in Japanese women.

Journal: Journal of human genetics

Published: September 09, 2025

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.

Utility of AMOY polymerase chain reaction panel in detecting non-small cell lung cancer using pleural cell block.

Journal: Japanese journal of clinical oncology

Published: September 04, 2025

Perinatal outcomes of fetal CNVs detected by genome-wide non-invasive prenatal testing in Japan.

Perinatal outcomes of fetal CNVs detected by genome-wide non-invasive prenatal testing in Japan.

Journal: Journal of human genetics

Published: July 25, 2025

Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors.

Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors.

Journal: Frontiers in immunology

Published: July 15, 2025

Guidelines for the management of pulmonary nodules detected by low-dose CT lung cancer screening 6th edition: compiled by the Japanese Society of CT Screening.

Guidelines for the management of pulmonary nodules detected by low-dose CT lung cancer screening 6th edition: compiled by the Japanese Society of CT Screening.

Journal: Japanese journal of radiology

Published: October 30, 2024

Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Prognostic Significance of Plasma Neutrophil Extracellular Trap Levels in Patients with Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Journal: Biomedicines

Published: July 04, 2024

Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Association between Immune-Related Adverse Events and Atezolizumab in Previously Treated Patients with Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.

Journal: Cancer research communications

Published: April 08, 2024

Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".

Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".

Journal: Thoracic cancer

Published: November 26, 2023

Showing 1-12 of 43

Last Updated: 09/26/2026